Google DeepMind advances disease detection and treatment with AI tools

Google: Google develops AI models and tools that support scientific research across biology and medicine. Its efforts in the news focus on applying these technologies to decode disease mechanisms, accelerate drug discovery, and improve clinical diagnostics through partnerships with global researchers and institutions. WHO AFRO: WHO AFRO is the World Health Organization’s regional office for Africa, coordinating public health initiatives across the continent. It utilized Google’s geospatial AI models to forecast disease outbreaks and improve response times for conditions like Ebola. DRC’s INRB: The DRC’s INRB is the Institut National de Recherche Biomédicale, the Democratic Republic of the Congo’s national biomedical research institute. It collaborated with WHO AFRO and Google on AI tools for identifying Ebola exposure and transmission risks. Makerere University: Makerere University is a major public research university in Uganda with strong programs in health sciences. Through its Infectious Disease Institute, it is applying Google’s AlphaFold and AlphaMissense to forecast malaria drug resistance mutations. University of Exeter: University of Exeter is a research university with expertise in genomics and aging-related biology. It collaborated with Google on using the AlphaGenome Atlas to identify genetic variants influencing protein levels linked to conditions like aging. Imperial College London: Imperial College London is a research university specializing in science, engineering, and medicine. It worked with Google and the UK’s NHS on studies evaluating AI mammography systems for cancer detection. University of Pennsylvania: University of Pennsylvania is a research university with prominent medical and engineering schools. It is using Google’s AlphaProteo and AlphaFold to design novel cellular therapies for solid tumors and complex diseases. Children’s Mercy Hospital: Children’s Mercy Hospital is a pediatric medical center focused on childhood diseases and treatments. It applied Google’s DeepSomatic tool to detect previously missed mutations in real-world leukemia cases. Institute for Global Health: The Institute for Global Health conducts research on infectious and neglected tropical diseases. It is featured in the news for using AlphaFold to screen compounds and identify repurposable drugs for Chagas disease in collaboration with Google. UK’s National Health Service: The UK’s National Health Service provides public healthcare across the United Kingdom. It collaborated with Google and Imperial College London on AI tools to support mammography screening and reduce radiologist workloads. Stanford University School of Medicine: Stanford University School of Medicine is a leading academic medical center focused on clinical research and training. It partnered with Google to apply DeepVariant and DeepConsensus for ultrarapid genome sequencing in time-critical genetic disease cases. Genomic Analysis Tools: Google’s biology models enable researchers to map genetic variants and reconstruct neural structures at high resolution for advancing medical discoveries. AI Research Collaboration: Google partners with academic and clinical institutions worldwide to translate AI models into practical tools for disease understanding and treatment. Public Health Forecasting: Google’s geospatial and flu prediction models support proactive outbreak response and seasonal illness preparedness for health authorities.